[Federal Register: May 13, 2002 (Volume 67, Number 92)]
[Notices]
[Page 32055]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13my02-99]
[[Page 32055]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Request for Nominations for Voting Members on Public Advisory
Committee; Veterinary Medicine Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for voting members to serve on the Veterinary Medicine
Advisory Committee (VMAC) in one of the following specialty areas:
Pharmacology, Minor Species/Minor Use Veterinary Medicine, and
pathology. Nominations for the VMAC chairperson are also being
solicited. Information regarding the committee can be found on the CVM
home page at http://www.fda.gov/cvm/index/vmac/vmactoc.htm.
FDA has a special interest in ensuring that women, minority groups,
and the physically challenged are adequately represented on advisory
committees and, therefore, encourages nominations of qualified
candidates from these groups.
DATES: FDA is seeking nominations for voting members, as well as,
nominations for the VMAC chairperson by May 15, 2002. Because scheduled
vacancies occur on various dates throughout each subsequent year, no
cutoff date for those specialty areas has been established.
ADDRESSES: All nominations and curricula vitae should be sent to the
appropriate contact person in the FOR FURTHER INFORMATION CONTACT
section of this document.
FOR FURTHER INFORMATION CONTACT:
Regarding nominations except for consumer representatives: Aleta
Sindelar, Center for Veterinary Medicine, Food and Drug Administration,
7519 Standish Pl., Rockville, MD 20855, 301-827-4515, e-mail:
asindela@cvm.fda.gov.
Regarding nominations for consumer representatives: Linda Sherman,
Advisory Committee Oversight and Management Staff (HF-4), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting
members to serve on the committee. The function of the VMAC is to
advise the Commissioner of Food and Drugs (the Commissioner) in
discharging their responsibilities as they relate to assuring safe and
effective drugs, feeds and feed additives, and devices for animal use,
and, as required, any other product for which FDA has regulatory
responsibility. The committee reviews and evaluates available data
concerning the safety and effectiveness of marketed and investigational
new animal drugs, feeds, and devices for use in the treatment and
prevention of animal diseases and increased animal production, and
makes appropriate recommendations to the Commissioner regarding
scientific issues and regulatory policies.
Qualifications
Persons nominated for membership on the committee shall have
adequately diversified experience that is appropriate to the work of
the committee in such fields as companion animal medicine, food animal
medicine, avian medicine, microbiology, biometrics, toxicology,
pathology, pharmacology, animal science, public health/epidemiology,
Minor Species/Minor Use Veterinary Medicine, and chemistry. The
specialized training and experience necessary to qualify the nominee as
an expert suitable for appointment is subject to review, but may
include experience in medical practice, teaching, and/or research
relevant to the field of activity of the committee. The term of office
is 4 years. The committee currently has three vacancies and is
requesting nominations for voting members to serve on one of the
following specialty areas: Pharmacology, Minor Species/Minor Use
Veterinary Medicine, and pathology. Nominations for the VMAC
chairperson are also being solicited.
Nomination Procedures
Any interested person may nominate one or more qualified persons
for membership on one or more of the advisory committees. Self-
nominations are also accepted. Nominations shall include the name of
the committee, a complete curriculum vitae of each nominee, current
business address and telephone number, and shall state that the nominee
is aware of the nomination, is willing to serve as a member, and
appears to have no conflict of interest that would preclude membership.
FDA will ask the potential candidates to provide detailed information
concerning such matters as financial holdings, employment, and research
grants and/or contracts to permit evaluation of possible sources of
conflict of interest.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.
Dated: May 2, 2002.
Bonnie Malkin,
Acting Senior Associate Commissioner for Communications and Constituent
Relations.
[FR Doc. 02-11787 Filed 5-10-02; 8:45 am]
BILLING CODE 4160-01-S